Kinnate Biopharma (KNTE)
NASDAQ:KNTE
Holding KNTE?
Track your performance easily

Kinnate Biopharma (KNTE) Balance Sheet

232 Followers

Kinnate Biopharma Balance Sheet

Kinnate Biopharma's total assets for Q4 2023 were $173.60M, a decrease of -8.97% from the previous quarter. KNTE total liabilities were $14.28M for the fiscal quarter, a -21.93% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 173.60M$ 278.83M$ 366.86M$ 400.57M$ 77.61M
Total Liabilities
$ 14.28M$ 20.36M$ 12.39M$ 7.30M$ 95.09M
Total Equity Gross Minority
$ 159.34M$ 258.47M$ 354.48M$ 393.27M$ -17.49M
Total Capitalization
$ 161.61M$ 226.66M$ 319.48M$ 393.27M$ -17.49M
Preferred Stock Equity
-----
Capital Lease Obligations
-----
Currency in USD

Kinnate Biopharma Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis